Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,188
Out of 5,154 analysts
45
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $28.81 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $75.74 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $237.01 | +35.02% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $90.90 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $30.02 | +59.89% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $175.42 | - | 4 | Apr 16, 2019 | |
| HSDT Solana Company | Downgrades: Neutral | n/a | $2.19 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Holdings | Upgrades: Buy | $80 | $123.59 | -35.27% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $8.96 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $103.50 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $109.56 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $71.35 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $68.10 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $81.64 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $28.81
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $75.74
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $237.01
Upside: +35.02%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $90.90
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $30.02
Upside: +59.89%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $175.42
Upside: -
Solana Company
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $2.19
Upside: -
iRhythm Holdings
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $123.59
Upside: -35.27%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $8.96
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $103.50
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $109.56
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $71.35
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $68.10
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $81.64
Upside: -